| Assessment Status | Rapid review complete |
| HTA ID | - |
| Drug | Etanercept |
| Brand | Benepali® |
| Indication | A biosimilar of the TNF-α inhibitor Etanercept (Enbrel®) for the treatment of patients with rheumatoid arthritis, psoriatic arthritis, axial spondylitis and plaque psoriasis. |
| Assessment Process | |
| Rapid review commissioned | 22/03/2016 |
| Rapid review completed | 10/05/2016 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended |